登录

HealAI Snares ¥10M in Series A Round

作者: Mailman 2020-02-20 18:11
万灵
http://www.healai.com
企业数据由 动脉橙 提供支持
精神科人工智能辅助诊断系统提供商 | A轮 | 运营中
中国-北京
2020-02-19
融资金额:近千万人民币
中山贝森医疗产业投资
查看

According to 36Kr.com, HealAI has completed its series A financing of tens of million yuan with participation from Zhongshan Beisen Medical Industry Investment. Proceeds of this round will be used for clinical trials of HealAI's products, and the follow-up registration and approval.


HealAI closed its ¥6.45 million angel round of financing in November 2016, led by Skyview Fund and XY Venture Capital, with participation from PreIPO. After that, it completed ¥15 million Pre-A round of financing invested by GP Healthcare Capital in 2018.


Founded in 2016, HealAI uses artificial intelligence (AI) to help patients with mental disorders. The company provides diagnosis and treatment services based on AI screening tools. It has independently developed the "HealAI Cloud" system, which can conduct pre-diagnosis and screening for mental disorders, and doctors can make specific consultations based on the results. Meanwhile, the system can also estimate prognosis and provide treatment plans and medication advice.


Mental disorders are different from other diseases with clear biological markers for diagnosis, they are mainly diagnosed and treated through questionnaire and interview. The whole process is time-consuming and relies on doctors' experience. The key to the treatment of mental disorders is how to improve the efficiency and accuracy of clinical diagnosis. JiJun, the founder of HealAI, said that AI is an important breakthrough, AI tools can be used for early screening.


HealAI's goal is not only the initial screening, but also including auxiliary diagnosis, and even diagnosis and treatment. The company has a clear product matrix, including products of depression auxiliary diagnosis, bipolar disorder auxiliary diagnosis, near-infrared auxiliary diagnosis, psychological iCBT intervention, and so on, covering both adults and children from screening to intervention.


>>>>

About Zhongshan Beisen Medical Industry Investment


Founded in 2017 with registered capital of 260 million yuan, Zhongshan Beisen Medical Industry Investment is a Beijing-based financial company under the management of Zhongshan Health Technology Park Development Co., Ltd. and some other companies.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

Changmugu Medical Snares ¥10M in Series A, Providing AI Applications in Orthopedics

CMCDI Invests in iFlytek Healthcare for 60 Million Yuan

Weiyun AI Snared Over 100 Million Yuan A Round Financing

医疗信息技术企业Notable Health完成4000万美元B轮融资,开发AI药物临床试验平台

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

半天内如何上线互联网诊疗服务?卓健科技用三种方案来解决 | 科技战疫

2020-02-20
下一篇

【生物医药日报】中国疾控中心:病毒通过污染衣物传染人几率极低;国家医保局明确新冠确诊或疑似患者先救治后结算

2020-02-20